Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dequalinium Chloride vs Metronidazole in Bacterial Vaginosis
NCT05788991Phase 4Terminated
- Sponsor
- Medinova AG
- Start
- Jul 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised, double-blind trial of dequalinium in bacterial vaginosis (BV) (2 arms), sponsored by Medinova AG. Primary endpoint: Clinical Cure Rate at 1 week. Started Jul 2021; status: terminated.
02
Drugs
dequalinium
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT05788991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05788991.